Latest Feature

Medicare: Medical device companies paid out $200m to physicians last year

Medical device companies' aggregate spend on payment and other gifts to physicians was at least $200 million last year, according to the U.S. Health & Human Services Dept., but critics (and the agency itself) flag widespread problems with the Open Payments database.

Checking on Orange County's medtech climate with OCTANe's Matthew Jenusaitis

Orange County, Calif.'s most-connected man, OCTANe's Matthew Jenusaitis talks to MassDevice.com about OCTANe's 2014 Medical Device Investor Forum.

What's behind the slump in early-stage medtech investment?

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for October 20, 2014

October 20, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Ablative Solutions tests infusion ablation catheter as hypertension treatment

October 20, 2014 by Alexander Soule

Ablative Solutions begins testing its infusion ablation catheter as a potential treatment for hypertension.

Ablative Solutions tests infusion ablation catheter as hypertension treatment

Medtronic's new line of spinal implants drops

October 20, 2014 by Brad Perriello

A new line of spinal implants from Medtronic makes its debut on the global stage.

Medtronic's new line of spinal implants drops worldwide

Medtronic (NYSE:MDT) said it's introduced a new line of spinal implants made of a titanium-plastic combination for interbody fusion procedures.

Boston Scientific launches stent trial for underserved demographics

October 20, 2014 by Brad Perriello

Boston Scientific launches a clinical trial examining outcomes in underserved populations with its Promus Premier drug-eluting stent.

Boston Scientific launches stent trial for underserved demographics

Diabetes: Medtronic initiates IDE trial for new insulin management system

October 20, 2014 by Alexander Soule

Medtronic has initiated an IDE clinical trial for its latest insulin-pump system as part of its quest to develop an "artificial pancreas" for the treatment of diabetes.

Medtronic initiates IDE trial for new insulin-pump system

ZipLine Medical adds $5.7m to Series C round

October 20, 2014 by Alexander Soule

A Chinese venture capital investor takes a $5.7 million stake in incision-closure device maker ZipLine Medical.

ZipLine Medical adds $5.7m to Series C round

ZipLine Medical said it added a $5.7 million extension to its $4.3 million Series C round, with new investor China Materialia promising to help the company expand sales in the People's Republic.

FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment

October 20, 2014 by Alexander Soule

AnthroTronix says it won FDA clearance for an app designed to help clinicians measure reaction time in assessing conditions like post-traumatic stress disorder and traumatic brain injury.

FDA clears AnthroTronix mobile app for PTSD, brain trauma assessment

AnthroTronix said it received FDA clearance for its DANA mobile assessment app, which is designed to help clinicians measure reaction time in assessing an individual's medical or psychological state.

Breast implant maker Sientra sets IPO range

October 20, 2014 by Alexander Soule

Breast implant maker Sientra raised the upper limit on its planned initial public offering of stock to $92 million, after filing in mid-September for an $86 million IPO.

Breast implant maker Sientra sets IPO range

Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO. 

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp